ANGO:NSD-AngioDynamics Inc (USD)

COMMON STOCK | Medical Instruments & Supplies | NSD

Last Closing Price

USD 24.14

Change

+0.69 (+2.94)%

Market Cap

USD 0.93B

Volume

0.13M

Avg Analyst Target

USD 34.00 (+40.85%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


ANGO Stock Forecast & Price:
Based on the AngioDynamics Inc stock forecasts from 2 analysts, the average analyst target price for AngioDynamics Inc is USD 34.00 over the next 12 months. AngioDynamics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of AngioDynamics Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, AngioDynamics Inc’s stock price was USD 24.14. AngioDynamics Inc’s stock price has changed by +2.46% over the past week, +18.22% over the past month and -10.49% over the last year.

About AngioDynamics Inc (ANGO:NSD)

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United State ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-10 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ISRG Intuitive Surgical Inc

+4.97 (+2.13%)

USD83.16B 59.87 38.75
HOLX Hologic Inc

+0.83 (+1.16%)

USD17.83B 11.82 7.74
RGEN Repligen Corporation

+11.36 (+4.64%)

USD13.59B 87.76 53.18
MASI Masimo Corporation

+9.61 (+6.49%)

USD8.58B 39.94 25.09
NVCR Novocure Ltd

+3.11 (+4.05%)

USD8.04B 1,480.87 -158.86
XRAY Dentsply Sirona Inc

+0.73 (+2.01%)

USD7.97B 22.02 10.96
QDEL Quidel Corporation

+4.53 (+5.24%)

USD5.89B 3.92 4.13
AZTA Azenta Inc

-1.95 (-3.05%)

USD5.17B 2.33 162.06
ICUI ICU Medical Inc

+5.01 (+3.01%)

USD4.29B 85.95 32.09
STAA STAAR Surgical Company

+4.55 (+5.49%)

USD4.19B 151.24 94.64

ETFs Containing ANGO

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Instruments & Supplies)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.47% 67% D+ 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.47% 67% D+ 53% F
Trailing 12 Months  
Capital Gain -10.72% 75% C 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.72% 75% C 56% F
Trailing 5 Years  
Capital Gain 47.56% 56% F 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.56% 56% F 64% D
Average Annual (5 Year Horizon)  
Capital Gain 23.24% 63% D 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.24% 63% D 80% B-
Risk Return Profile  
Volatility (Standard Deviation) 70.32% 34% F 18% F
Risk Adjusted Return 33.06% 53% F 66% D
Market Capitalization 0.93B 58% F 68% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Instruments & Supplies)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 7.10 83% B 80% B-
Price/Book Ratio 2.14 64% D 42% F
Price / Cash Flow Ratio -128.82 94% A 90% A-
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -6.15% 45% F 44% F
Return on Invested Capital -5.52% 41% F 40% F
Return on Assets -2.50% 52% F 41% F
Debt to Equity Ratio 5.89% 75% C 78% C+
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 4.44 48% F 34% F
Short Percent 4.18% 39% F 38% F
Beta 0.90 74% C 62% D-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector